HeartSciences files proxy for Fortitude Mining all-stock merger; FY2026 cash $1.7M, no revenue

HeartSciences Inc.

Filed preliminary proxy for all-stock merger with Fortitude Mining; ~107.6M shares to DCG, pro forma equity $70M.
Fortitude mined 72,696 ZEC in H1 2026 (~28% of network); new 60MW Nebraska facility energized.
At Zcash >$500, Fortitude estimates run-rate Adj. EBITDA >$50M once new machines hashing.
FY2026: no meaningful revenue, cash $1.7M, shareholders' equity $0.2M.
MyoVista Insights platform launched commercially; MyoVista wavECG under FDA 510(k) review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.